Opioid agonist treatment uptake within provincial correctional facilities in British Columbia, Canada.

ABSTRACT:

Background and aims

Multiple interventions and policy changes related to opioid agonist treatment (OAT) have been introduced in British Columbia, Canada to increase engagement and retention in OAT. We aimed to estimate the impact of policy changes and the announcement of the opioid overdose-related public health emergency on the use of OAT for incarcerated individuals with opioid use disorder.

Design

Interrupted time-series analysis. Events of interest included the expansion of buprenorphine/naloxone into provincial health-care insurance coverage in October 2015 and the public health emergency declared in April 2016.

Setting and participants

Our study included 9220 incarcerated individuals from 12 provincial corrections facilities in British Columbia, Canada for a tot

SUBMITTER: Kurz M 

PROVIDER: S-EPMC9835718 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature